Expression of GRP and its receptor is associated with improved survival in patients with colon cancer

Clinical and Experimental Metastasis

Volumn 26, Issue 7, 2009, Pages 663-671

  Rivera, Claudio A ^a,b   Ahlberg, Ned C ^a,b   Taglia, Lauren ^a,b   Kumar, Mayank ^a,b   Blunier, Adam ^a,b   Benya, Richard V ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Bombesin; Survival

Indexed keywords

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR;

AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL ADHESION; COLON CANCER; CONTROLLED STUDY; CYTOLYSIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NATURAL KILLER CELL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; COLONIC NEOPLASMS; GASTRIN-RELEASING PEPTIDE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MOLECULAR SEQUENCE DATA; RECEPTORS, BOMBESIN; SURVIVAL ANALYSIS;

EID: 71849115937     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-009-9265-8     Document Type: Article

References (51)

1. JG McCoy DD Avery 1990 Bombesin: potential integrative peptide for feeding and satiety Peptides 11 595 607 10.1016/0196-9781(90)90064-C 10.1016/0196-9781(90)90064-C 1:CAS:528:DyaK3cXkvFWntbg%3D 2199952 (Pubitemid 20186637)
2. MR Brown K Carver LA Fisher 1988 Bombesin: central nervous system actions to affect the autonomic nervous system Ann N Y Acad Sci 547 174 182 10.1111/j.1749-6632.1988.tb23885.x 10.1111/j.1749-6632.1988.tb23885.x 1:CAS:528:DyaL1MXltV2jtLw%3D 3071216
3. HE Albers SY Liou EG Stopa, et al. 1991 Interaction of colocalized neuropeptides: functional significance in the circadian timing system J Neurosci 11 846 851 1:CAS:528:DyaK3MXlt1Okurg%3D 2002363
4. CR Severi RT Jensen V Erspamer, et al. 1991 Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells Am J Physiol 260 G683 G690 1:CAS:528:DyaK3MXks1GitL8%3D 1852115
5. M De La Fuente M Del Rio A Hernanz 1993 Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: involvement of cyclic AMP, inositol 1, 4, 5-trisphosphate and protein kinase C Ann Oncol 4 499 507
6. MA Ghatei RT Jung JC Stevenson, et al. 1982 Bombesin action on gut hormones and calcium in man J Clin Endocrinol Metab 54 980 985 10.1210/jcem-54-5-980 1:CAS:528:DyaL38XitFWgtrk%3D 7061703
7. RE Carroll KA Matkowskyj Y Saunthararajah, et al. 2002 Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract Mech Dev 113 121 130 10.1016/S0925-4773(02) 00032-1 10.1016/S0925-4773(02)00032-1 1:CAS:528:DC%2BD38XivVSmtrs%3D 11960700 (Pubitemid 34311738)
8. F Cuttitta DN Carney J Mulshine, et al. 1985 Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer cells Nature 316 823 826 10.1038/316823a0 10.1038/316823a0 1:CAS:528: DyaL2MXlslamu7c%3D 2993906 (Pubitemid 15003742)
9. MH Corjay DJ Dobrzanski JM Way, et al. 1991 Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells J Biol Chem 266 18771 18779 1:CAS:528:DyaK38Xit1yltrk%3D 1655761
10. F Hohla AV Schally CA Kanashiro, et al. 2007 Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt Proc Natl Acad Sci USA 104 18671 18676 10.1073/pnas.0709455104 10.1073/pnas.0709455104 1:CAS:528:DC%2BD2sXhtl2ku7bI 18003891 (Pubitemid 350210755)
11. T Yano J Pinski K Groot, et al. 1992 Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines Cancer Res 52 4545 4547 1:CAS:528: DyaK38Xls1Cgsbw%3D 1643647
12. W Guojun G Wei O Kedong, et al. 2008 A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo Endocr Relat Cancer 15 149 159 10.1677/ERC-07-0224 10.1677/ERC-07-0224 18310283
13. J Pinski G Halmos T Yano, et al. 1994 Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160 Int J Cancer 57 574 580 10.1002/ijc.2910570422 10.1002/ijc.2910570422 1:CAS:528:DyaK2cXmt1Witbo%3D 7910153 (Pubitemid 24173105)
14. HJ Kim BM Evers Y Guo, et al. 1996 Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA) Surgery 120 130 136 10.1016/S0039-6060(96)80279-0 10.1016/S0039-6060(96)80279-0 1:STN:280:DyaK28zltVegsQ%3D%3D 8751574
15. B Ohlsson N Fredang J Axelson 1999 The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines Scand J Gastroenterol 34 1224 1229 10.1080/003655299750024742 10.1080/003655299750024742 1:CAS:528:DC%2BD3cXlsVOiuw%3D%3D 10636070
16. Q Wang AV Schally PM Pour, et al. 1996 Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway Int J Cancer 68 528 534 10.1002/(SICI)1097-0215(19961115)68:4<528::AID- IJC20>3.0.CO;2-# 10.1002/(SICI)1097-0215(19961115)68:4<528::AID- IJC20>3.0.CO;2-# 1:CAS:528:DyaK2sXosFyi 8945626 (Pubitemid 26414510)
17. J Pinski AV Schally G Halmos, et al. 1994 Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo Cancer Res 54 5895 5901 1:CAS:528:DyaK2MXitV2qs70%3D 7954420
18. D Xiao X Qu HC Weber 2003 Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells Cell Signal 15 945 953 10.1016/S0898-6568(03)00059-7 10.1016/S0898-6568(03) 00059-7 1:CAS:528:DC%2BD3sXlsVagtrg%3D 12873708 (Pubitemid 36859806)
19. S Radulovic G Miller AV Schally 1991 Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095) Cancer Res 51 6006 6009 1:CAS:528:DyaK38XhsFCmuw%3D%3D 1682040
20. JC Saurin M Fallavier B Sordat, et al. 2002 Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner Cancer Res 62 4829 4835 1:CAS:528:DC%2BD38XmsVShtr0%3D 12183443
21. RT Jensen DH Coy 1991 Progress in the development of potent bombesin receptor antagonists Trends Pharmacol Sci 12 13 19 10.1016/0165-6147(91)90483-9 10.1016/0165-6147(91)90483-9 1:CAS:528:DyaK3MXltVKitrg%3D 1706545
22. RT Jensen JF Battey ER Spindel, et al. 2008 International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states Pharmacol Rev 60 1 42 10.1124/pr.107.07108 10.1124/pr.107.07108 1:CAS:528: DC%2BD1cXks1GjsLk%3D 18055507
23. AV Schally 2008 New approaches to the therapy of various tumors based on peptide analogues Hormone and Metabolic Research. Hormon- und Stoffwechselforschung. Hormones et Metabolisme 40 315 322 10.1055/s-2008-1073142 1:CAS:528:DC%2BD1cXotFyrsbs%3D 18491250 (Pubitemid 351859442)
24. JG Jensen RE Carroll RV Benya 2001 The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer Peptides 22 689 699 10.1016/S0196-9781(01)00380-1 10.1016/S0196-9781(01) 00380-1 1:CAS:528:DC%2BD3MXislKjsrk%3D 11311741 (Pubitemid 32322728)
25. MJ Kelley I Linnoila IL Avis, et al. 1997 Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer Chest 112 256 261 10.1378/chest.112.1.256 10.1378/chest.112.1.256 1:CAS:528:DyaK2sXltFalsr0%3D 9228385
26. M Toi-Scott CL Jones MA Kane 1996 Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells Lung Cancer (Amsterdam, Netherlands) 15 341 354 10.1016/0169-5002(95)00597-8 1:STN:280:DyaK2s7hvVygtQ%3D%3D (Pubitemid 26399513)
27. RE Carroll KA Matkowskyj S Chakrabarti, et al. 1999 Aberrant expression of gastrin-releasing peptide and its receptor by well differentiated colon cancers in humans Am J Physiol 276 G655 G665 1:CAS:528:DyaK1MXit1Sqsbw%3D 10070042
28. S Glover M Delaney C Dematte, et al. 2004 Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties J Cell Physiol 199 77 88 10.1002/jcp.10456 10.1002/jcp.10456 1:CAS:528:DC%2BD2cXhs1SksLY%3D 14978737 (Pubitemid 38197516)
29. L Taglia D Matusiak KA Matkowskyj, et al. 2007 Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by up-regulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol 292 G182 G190 1:CAS:528:DC%2BD2sXisFCqu7o%3D
30. + natural killer cell binding to colon cancer cells causing tumor cell cytolysis. Clin Exp Metastasis 25:451-463
31. Redston M (2008) Epithelial neoplasms of the large intestine. In: Odze RD, Goldblum JR, Crawford JM (eds) Surgical pathology of the GI tract, liver, biliary tract and pancreas. Elsevier Health Sciences, New York
32. KA Matkowskyj K Keller S Glover, et al. 2003 Expression of GRP and its receptor in well differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407 J Histochem Cytochem 51 1041 1048 1:CAS:528:DC%2BD3sXlvFyrtrc%3D 12871985
33. KA Matkowskyj D Schonfeld RV Benya 2000 Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab J Histochem Cytochem 48 303 311 1:CAS:528: DC%2BD3cXhsVGnu7w%3D 10639497
34. KA Matkowskyj R Cox RT Jensen, et al. 2003 Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures protein concentration J Histochem Cytochem 51 205 214 1:CAS:528: DC%2BD3sXptVKitQ%3D%3D 12533529
35. Matkowskyj KA, Cox R, Benya RV (2006) Quantitative immunohistochemistry by determining the norm of the image file. In: Hayat MA (ed) Immunohistochemistry of in situ hybridization of human carcinomas. Academic Press, Burlington, MA, pp 279-284
36. K Matkowskyj S Glover R Benya 2004 Quantitative immunohistochemistry: an algorithm measuring cumulative signal strength and receptor number Microsc Anal 18 5 6
37. JF Battey JM Way MH Corjay, et al. 1991 Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells Proc Natl Acad Sci USA 88 395 399 10.1073/pnas.88.2.395 10.1073/pnas.88.2.395 1:CAS:528:DyaK3MXks1Gktrk%3D 1671171
38. ER Spindel E Giladi P Brehm, et al. 1990 Cloning and functional characterization of a complimentary DNA encoding the murine fibroblast bomesin/gastrin-releasing peptide receptor Mol Endocrinol 4 1956 1963 10.1210/mend-4-12-1956 1:CAS:528:DyaK3MXlsFaitL8%3D 1707129
39. RE Carroll R Carroll RV Benya 1999 Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas Peptides 20 229 237 10.1016/S0196-9781(98)00164-8 10.1016/S0196-9781(98)00164-8 1:CAS:528:DyaK1MXksFSktbY%3D 10422879 (Pubitemid 29332105)
40. N/A (2008) Surveillance epidemiology and end results ( http://seer.cancer.gov ). National Cancer Institute
41. Schumacher P, Dineen S, Barnett C Jr et al (2007) The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 194:827-831. discussion 831-822. doi: 10.1016/j.amjsurg.2007.08.030 (Pubitemid 350086537)
42. HY Lee HJ Choi KJ Park, et al. 2007 Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma Ann Surg Oncol 14 1712 1717 10.1245/s10434-006-9322-3 10.1245/s10434-006-9322-3 17253102 (Pubitemid 46791006)
43. J Wang JM Hassett MT Dayton, et al. 2008 Lymph node ratio: role in the staging of node-positive colon cancer Ann Surg Oncol 15 1600 1608 10.1245/s10434-007-9716-x 10.1245/s10434-007-9716-x 18327530
44. TA Ruginis L Taglia D Matusiak, et al. 2006 Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach J Proteome Res 5 1460 1468 10.1021/pr060005g 10.1021/pr060005g 1:CAS:528:DC%2BD28XktVerurY%3D 16739997 (Pubitemid 43865814)
45. A Asea 2005 Stress proteins and initiation of immune response: chaperokine activity of hsp72 Exerc Immunol Rev 11 34 45 16385842
46. D Matusiak S Glover R Nathaniel, et al. 2005 Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol 288 G718 G728 10.1152/ajpgi.00156. 2004 10.1152/ajpgi.00156.2004 1:CAS:528:DC%2BD2MXjtlyjsbk%3D 15528253 (Pubitemid 40388183)
47. HA Ferris RE Carroll MM Rasenick, et al. 1997 Constitutive activation of the gastrin-releasing peptide receptor expressed by the non-malignant human colon epithelial cell line NCM460 J Clin Invest 100 2530 2537 10.1172/JCI119795 10.1172/JCI119795 1:CAS:528:DyaK2sXnsVymtb4%3D 9366567
48. J Jiang CC Hui 2008 Hedgehog signaling in development and cancer Dev Cell 15 801 812 10.1016/j.devcel.2008.11.010 10.1016/j.devcel.2008.11.010 1:CAS:528:DC%2BD1cXhsFWgsbjN 19081070
49. M Nilsen-Hamilton 1990 Transforming growth factor-beta and its actions on cellular growth and differentiation Curr Top Dev Biol 24 95 136 10.1016/S0070-2153(08)60085-X 10.1016/S0070-2153(08)60085-X 1:CAS:528: DyaK3MXkt1agsrg%3D 2165898
50. M Subramaniam K Sugiyama DH Coy, et al. 2003 Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med 168 601 611 10.1164/rccm.200212-1434OC 10.1164/rccm.200212-1434OC 12807697 (Pubitemid 37088605)
51. HC Weber 2009 Regulation and signaling of human bombesin receptors and their biological effects Curr Opin Endocrinol Diabetes Obes 16 66 71 1:CAS:528:DC%2BD1cXhsFCnu7nL 19115523